The performance of HCV GT plus RUO reagent in determining Hepatitis C virus genotypes in Taiwan
暂无分享,去创建一个
Ming‐Lung Yu | M. Yeh | Chung‐Feng Huang | C. Dai | M. Hsieh | Shinn‐Chern Chen | Jee-Fu Huang | W. Chuang | Ying-Chou Huang | Shu-Fen Liu | Hung-Yin Liu | M. Yu | Ching‐I. Huang | Ching-I Huang | Jee‐Fu Huang | Chung-Feng Huang
[1] M. Buti,et al. Healthcare value of implementing hepatitis C screening in the adult general population in Spain , 2018, PLoS ONE.
[2] Ming‐Lung Yu,et al. Updates in the management and treatment of HCV genotype 3, what are the remaining challenges? , 2018, Expert review of anti-infective therapy.
[3] T. Pilot‐Matias,et al. Hepatitis C virus genetic diversity by geographic region within genotype 1-6 subtypes among patients treated with glecaprevir and pibrentasvir , 2018, PloS one.
[4] H. Mo,et al. Identification of a Novel Hepatitis C Virus Genotype From Punjab, India: Expanding Classification of Hepatitis C Virus Into 8 Genotypes , 2018, The Journal of infectious diseases.
[5] J. Germer,et al. Utility of the Abbott RealTime HCV Genotype Plus RUO assay used in combination with the Abbott RealTime HCV Genotype II assay. , 2018, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[6] Ming‐Lung Yu,et al. The outcomes of glucose abnormalities in chronic hepatitis C patients receiving interferon‐free direct antiviral agents , 2017, The Kaohsiung journal of medical sciences.
[7] Kristof Theys,et al. Epidemic dispersion of HIV and HCV in a population of co-infected Romanian injecting drug users , 2017, PloS one.
[8] G. Cloherty,et al. Evaluation of the Abbott RealTime HCV genotype II plus RUO (PLUS) assay with reference to core and NS5B sequencing. , 2017, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[9] Mohammad-Ayman A. Safi. Hepatitis C: an Overview of Various Laboratory Assays with their Mode of Diagnostic Cooperation. , 2017, Clinical laboratory.
[10] Gamal Esmat,et al. Global prevalence and genotype distribution of hepatitis C virus infection in 2015: a modelling study. , 2017, The lancet. Gastroenterology & hepatology.
[11] E. Gould,et al. ICTV Virus Taxonomy Profile: Flaviviridae , 2017, The Journal of general virology.
[12] Ming‐Lung Yu,et al. A real‐world impact of cost‐effectiveness of pegylated interferon/ribavarin regimens on treatment‐naïve chronic hepatitis C patients in Taiwan , 2017, The Kaohsiung journal of medical sciences.
[13] F. Tacke,et al. Management of hepatitis C virus infection in the Asia-Pacific region: an update. , 2017, The lancet. Gastroenterology & hepatology.
[14] E. Tapper,et al. Direct costs of care for hepatocellular carcinoma in patients with hepatitis C cirrhosis , 2016, Cancer.
[15] A. Roque-Afonso,et al. Characterization of Samples Identified as Hepatitis C Virus Genotype 1 without Subtype by Abbott RealTime HCV Genotype II Assay Using the New Abbott HCV Genotype Plus RUO Test , 2015, Journal of Clinical Microbiology.
[16] P. Tangkijvanich,et al. Genotypic Distribution of Hepatitis C Virus in Thailand and Southeast Asia , 2015, PloS one.
[17] M. Yeh,et al. Host and virological characteristics of patients with hepatitis C virus mixed genotype 1 and 2 infection , 2015, The Kaohsiung journal of medical sciences.
[18] A. Flaxman,et al. Global Distribution and Prevalence of Hepatitis C Virus Genotypes , 2014, Hepatology.
[19] H. Razavi,et al. Global epidemiology and genotype distribution of the hepatitis C virus infection. , 2014, Journal of hepatology.
[20] Chien-Jen Chen,et al. Hepatitis C virus genotype 1b increases cumulative lifetime risk of hepatocellular carcinoma , 2014, International journal of cancer.
[21] Lai Wei,et al. Performance Comparison of the Versant HCV Genotype 2.0 Assay (LiPA) and the Abbott Realtime HCV Genotype II Assay for Detecting Hepatitis C Virus Genotype 6 , 2014, Journal of Clinical Microbiology.
[22] K. Pabbaraju,et al. The need for a sequencing-based assay to supplement the Abbott m2000 RealTime HCV Genotype II assay: a 1 year analysis. , 2014, Journal of clinical virology : the official publication of the Pan American Society for Clinical Virology.
[23] J. Hoofnagle,et al. Important Factors in Reliable Determination of Hepatitis C Virus Genotype by Use of the 5′ Untranslated Region , 2013, Journal of Clinical Microbiology.
[24] Ming‐Lung Yu,et al. Chronic hepatitis C infection in the elderly , 2011, The Kaohsiung journal of medical sciences.
[25] F. Sanai,et al. A systematic review of hepatitis C virus epidemiology in Asia, Australia and Egypt , 2011, Liver international : official journal of the International Association for the Study of the Liver.
[26] Ming‐Lung Yu,et al. Viral Hepatitis Infections in Southern Taiwan: A Multicenter Community‐based Study , 2010, The Kaohsiung journal of medical sciences.
[27] Yuan-Ming Lee,et al. Molecular epidemiology of HCV genotypes among injection drug users in Taiwan: Full‐length sequences of two new subtype 6w strains and a recombinant form_2b6w , 2010, Journal of medical virology.
[28] Ming‐Lung Yu,et al. Hepatitis C Virus Infection And Metabolic Syndrome—A Community‐Based Study in an Endemic Area of Taiwan , 2009, The Kaohsiung journal of medical sciences.
[29] Ming‐Lung Yu,et al. Treatment of chronic hepatitis C in Asia: When East meets West , 2009, Journal of gastroenterology and hepatology.
[30] Shang-Jyh Hwang,et al. Reappraisal of the Characteristics of Glucose Abnormalities in Patients With Chronic Hepatitis C Infection , 2008, The American Journal of Gastroenterology.
[31] S. Sarin,et al. Asian Pacific Association for the Study of the Liver consensus statements on the diagnosis, management and treatment of hepatitis C virus infection , 2007, Journal of gastroenterology and hepatology.
[32] P. de Micco,et al. Improvement of Hepatitis C Virus (HCV) Genotype Determination with the New Version of the INNO-LiPA HCV Assay , 2007, Journal of Clinical Microbiology.
[33] C. Hagedorn,et al. Hepatitis C virus genotype distribution in China: Predominance of closely related subtype 1b isolates and existence of new genotype 6 variants , 2005, Journal of medical virology.
[34] J. Pawlotsky,et al. Comparison of Hepatitis C Virus NS5b and 5′ Noncoding Gene Sequencing Methods in a Multicenter Study , 2005, Journal of Clinical Microbiology.
[35] M. Manns,et al. A comparison of fibrosis progression in chronic liver diseases. , 2003, Journal of hepatology.
[36] V. Sundararajan,et al. Southeast Asian patients with chronic hepatitis C: The impact of novel genotypes and race on treatment outcome , 2002, Hepatology.
[37] Sheng-Nan Lu,et al. Hepatitis C virus infection among teenagers in an endemic township in Taiwan: epidemiological and clinical follow-up studies , 2001, Epidemiology and Infection.
[38] Jing-Houng Wang,et al. Changing prevalence of hepatitis C virus genotypes: Molecular epidemiology and clinical implications in the hepatitis C virus hyperendemic areas and a tertiary referral center in Taiwan , 2001, Journal of medical virology.
[39] M. Yu,et al. A hyperendemic community of hepatitis B virus and hepatitis C virus infection in Taiwan. , 1999, Transactions of the Royal Society of Tropical Medicine and Hygiene.
[40] M. Mondelli,et al. Hepatitis C virus genotypes and risk of hepatocellular carcinoma in cirrhosis: A prospective study , 1997, Hepatology.
[41] L. Y. Wang,et al. The genotypes of hepatitis C virus in patients with chronic hepatitis C virus infection in southern Taiwan. , 1996, The Kaohsiung journal of medical sciences.
[42] Ding‐Shinn Chen,et al. Genotypes of hepatitis C virus in chronic liver disease in Taiwan , 1994, Journal of medical virology.
[43] T. Miyamura,et al. The particle size of hepatitis C virus estimated by filtration through microporous regenerated cellulose fibre. , 1991, The Journal of general virology.
[44] Kao-hsiung i hsüeh yüan. 高雄醫學科學雜誌 = The Kaohsiung journal of medical sciences , 1985 .